Real Chemistry

Real Chemistry is a global health innovation company based in San Francisco, formed from the rebranding of W2O Group in March 2021. Founded in 2001 by CEO Jim Weiss, the company has grown to nearly 1,700 employees and serves many of the top 30 global biopharma and biotech companies. Real Chemistry focuses on modern healthcare challenges with data-driven, digital-first strategies across commercial, clinical, and corporate domains. The company offers a range of services, including integrated communications, advertising and medical strategy, value-based care consulting, influencer and entertainment marketing, and clinical trial engagement. Real Chemistry also provides proprietary products such as Swoop, an analytics platform for healthcare data insights; IPM.ai, which focuses on predictive analytics; and the Symplur Suite, designed for social listening and engagement in healthcare conversations. Their approach combines expertise, technology, and data analytics to enhance patient outcomes and optimize healthcare strategies.